MonumenTAL-6

64407564MMY3009: A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in Combination With Teclistamab (Tal-Tec), and Investigator's Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pom

Near Add Your Location

Sorting 8 by

Medical Oncology Hematology Consultants PA
in ChristianaCare Helen F. Graham Cancer Center & Research Institute
Newark, DE
  • Accepting patients
Weill Cornell
New York, NY
  • Accepting patients
City of Hope - Atlanta
Southeastern Regional Medical Center
Newnan, GA
  • Accepting patients
SUNY Upstate Medical University
State University of New York
Syracuse, NY
  • Accepting patients
University of Maryland Medical Center
Marlene and Stewart Greenebaum Comprehensive Cancer Center
Baltimore, MD
  • Accepting patients
MUSC Hollings Cancer Center
Medical University of South Carolina
Charleston, SC
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.